Literature DB >> 1986023

Osteomalacia in hereditary hypophosphatemic rickets with hypercalciuria: a correlative clinical-histomorphometric study.

D Gazit1, M Tieder, U A Liberman, L Passi-Even, I A Bab.   

Abstract

We characterized the bone disease of transilial biopsy specimens from children with hereditary hypophosphatemic rickets with hypercalciuria (HHRH) and genetically related asymptomatic hypercalciuric subjects. All HHRH patients showed irregular mineralization fronts, markedly elevated osteoid surface and seam width, increased number of osteoid lamellae, and prolonged mineralization lag time. These findings are consistent with a mineralization defect and indicate unambiguously that the bone disease in HHRH is osteomalacia. The only abnormality seen in the asymptomatic hypercalciuric subjects was slightly extended osteoid surface. Parametric and nonparametric statistical analyses performed on a pooled sample of HHRH patients and asymptomatic hypercalciuric subjects revealed a very high inverse correlation and a tight linear relationship between serum phosphorus and osteoid parameters. Serum 1,25-dihydroxyvitamin D, which is low in other forms of hereditary hypophosphatemia and osteomalacia, is elevated in HHRH and correlated positively with osteoid parameters and the mineralization lag time. Serum alkaline phosphatase showed similar relationships. These results as well as the clinical, biochemical, and radiological remission of bone disease consequent to phosphate therapy strongly suggest that in HHRH 1) hypophosphatemia alone is sufficient to cause osteomalacia; and 2) the elevation of 1,25-dihydroxyvitamin D reflects the degree of the primary renal phosphate leak, but is not involved in the pathogenesis of the bone disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986023     DOI: 10.1210/jcem-72-1-229

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Hypophosphatemic rickets.

Authors:  L A DiMeglio; M J Econs
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  An ethyl-nitrosourea-induced point mutation in phex causes exon skipping, x-linked hypophosphatemia, and rickets.

Authors:  Marina R Carpinelli; Ian P Wicks; Natalie A Sims; Kristy O'Donnell; Katherine Hanzinikolas; Rachel Burt; Simon J Foote; Melanie Bahlo; Warren S Alexander; Douglas J Hilton
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities.

Authors:  L Beck; A C Karaplis; N Amizuka; A S Hewson; H Ozawa; H S Tenenhouse
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

4.  SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis.

Authors:  Clemens Bergwitz; Nicole M Roslin; Martin Tieder; J C Loredo-Osti; Murat Bastepe; Hilal Abu-Zahra; Danielle Frappier; Kelly Burkett; Thomas O Carpenter; Donald Anderson; Michele Garabedian; Isabelle Sermet; T Mary Fujiwara; Kenneth Morgan; Harriet S Tenenhouse; Harald Juppner
Journal:  Am J Hum Genet       Date:  2005-12-09       Impact factor: 11.025

5.  A patient with hypophosphatemia, a femoral fracture, and recurrent kidney stones: report of a novel mutation in SLC34A3.

Authors:  Kathleen Page; Clemens Bergwitz; Graciana Jaureguiberry; Chittari V Harinarayan; Karl Insogna
Journal:  Endocr Pract       Date:  2008-10       Impact factor: 3.443

6.  Hereditary hypophosphatemic rickets with hypercalciuria: a study for the phosphate transporter gene type IIc and osteoblastic function.

Authors:  Takehisa Yamamoto; Toshimi Michigami; Fumito Aranami; Hiroko Segawa; Kousei Yoh; Shigeo Nakajima; Ken-ichi Miyamoto; Keiichi Ozono
Journal:  J Bone Miner Metab       Date:  2007-10-25       Impact factor: 2.626

7.  Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/type IIc sodium-phosphate cotransporter: presentation as hypercalciuria and nephrolithiasis.

Authors:  Amanda L Tencza; Shoji Ichikawa; Anna Dang; David Kenagy; Edward McCarthy; Michael J Econs; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

Review 8.  Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy.

Authors:  Clemens Bergwitz; Ken-Ichi Miyamoto
Journal:  Pflugers Arch       Date:  2018-08-14       Impact factor: 3.657

9.  SLC34A3 intronic deletion in a new kindred with hereditary hypophosphatemic rickets with hypercalciuria.

Authors:  Shirin Hasani-Ranjbar; Mahsa M Amoli; Azadeh Ebrahim-Habibi; Ehsan Dehghan; Akbar Soltani; Parvin Amiri; Bagher Larijani
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.